Holen Sie sich die Stockscreener-App
5.39
2.28%
0.12
Handel nachbörslich:
5.50
0.11
+2.04%
Schlusskurs vom Vortag:
$5.27
Offen:
$5.29
24-Stunden-Volumen:
37,319
Relative Volume:
0.31
Marktkapitalisierung:
$304.70M
Einnahmen:
$34.16M
Nettoeinkommen (Verlust:
$-98.43M
KGV:
-2.3034
EPS:
-2.34
Netto-Cashflow:
$-119.33M
1W Leistung:
+7.58%
1M Leistung:
+4.86%
6M Leistung:
+22.78%
1J Leistung:
-32.37%
1-Tages-Spanne:
$5.14
$5.40
1-Wochen-Bereich:
$4.90
$5.4573
52-Wochen-Spanne:
$2.9448
$10.25
Foghorn Therapeutics Inc Stock (FHTX) Company Profile
Firmenname
Foghorn Therapeutics Inc
Sektor
Branche
Telefon
617-586-3100
Adresse
500 TECHNOLOGY SQUARE, CAMBRIDGE
Vergleichen Sie FHTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FHTX
Foghorn Therapeutics Inc
|
5.39 | 298.48M | 34.16M | -98.43M | -119.33M | -2.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-23 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-01-30 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-03 | Eingeleitet | Jefferies | Buy |
| 2024-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2023-03-28 | Eingeleitet | BofA Securities | Buy |
| 2023-01-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-11-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-17 | Eingeleitet | Cowen | Outperform |
| 2020-11-17 | Eingeleitet | Goldman | Buy |
| 2020-11-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-17 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Foghorn Therapeutics Inc Aktie (FHTX) Neueste Nachrichten
Does Foghorn Therapeutics Inc. have high return on assetsEarnings Risk Summary & Fast Moving Trade Plans - khodrobank.com
Backtesting results for Foghorn Therapeutics Inc. trading strategiesQuarterly Earnings Report & Expert Approved Momentum Trade Ideas - Newser
Trend analysis for Foghorn Therapeutics Inc. this week2025 Key Lessons & Safe Investment Capital Preservation Plans - Newser
How did FHTX's Q4 2024 earnings surprise impact investor confidence? - AInvest
What earnings revisions data tells us about Foghorn Therapeutics IncEarnings Risk Report & AI Forecast Swing Trade Picks - Newser
What earnings revisions data tells us about Foghorn Therapeutics Inc.Weekly Trend Report & Proven Capital Preservation Tips - Newser
AI Indicators Detect Buy Opportunity in Foghorn Therapeutics Inc.July 2025 Movers & Technical Confirmation Alerts - beatles.ru
Combining price and volume data for Foghorn Therapeutics Inc.Market Performance Summary & Precise Swing Trade Alerts - Newser
Heatmap analysis for Foghorn Therapeutics Inc. and competitors2025 Market Overview & Free Accurate Trade Setup Notifications - Newser
Foghorn Therapeutics Advances in Precision Therapeutics - TipRanks
Using RSI to spot recovery in Foghorn Therapeutics Inc.2025 Market Sentiment & Smart Investment Allocation Tips - Newser
What’s the analyst consensus on Foghorn Therapeutics Inc.July 2025 Reactions & Accurate Intraday Trade Tips - khodrobank.com
Has Foghorn Therapeutics Inc. found a price floorQuarterly Trade Summary & Daily Entry Point Alerts - Newser
Is Foghorn Therapeutics Inc. a good ESG investmentJuly 2025 Price Swings & Low Drawdown Trading Strategies - khodrobank.com
Uveal Melanoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Novartis, Foghorn Therapeutics Inc., TriSalus Life Sciences, Inc., AstraZeneca - The Globe and Mail
How to track smart money flows in Foghorn Therapeutics Inc.Weekly Investment Recap & Free Growth Oriented Trading Recommendations - Newser
Foghorn Therapeutics Inc. stock trend forecastPortfolio Value Report & Safe Entry Momentum Tips - Newser
Does Foghorn Therapeutics Inc. have pricing powerLayoff News & Technical Buy Zone Confirmation - khodrobank.com
When is the best time to exit Foghorn Therapeutics Inc.July 2025 Volume & Fast Exit and Entry Strategy Plans - Newser
Is Foghorn Therapeutics Inc. a speculative investmentWeekly Stock Recap & AI Driven Stock Movement Reports - khodrobank.com
Is Foghorn Therapeutics Inc. vulnerable to short sellers2025 Price Momentum & Stepwise Entry/Exit Trade Alerts - khodrobank.com
Does Foghorn Therapeutics Inc. stock benefit from AI growth2025 Market Trends & Weekly High Conviction Ideas - khodrobank.com
Can Foghorn Therapeutics Inc. expand into new marketsJuly 2025 Rallies & AI Enhanced Execution Alerts - khodrobank.com
Ranking Foghorn Therapeutics Inc. among high performing stocks via toolsJuly 2025 Catalysts & Weekly Momentum Picks - Newser
Can Foghorn Therapeutics Inc. stock double in the next yearWeekly Stock Recap & Expert Approved Trade Ideas - khodrobank.com
Wall Street Analysts Predict a 130.63% Upside in Foghorn Therapeutics (FHTX): Here's What You Should Know - Yahoo Finance
How to build a custom watchlist for Foghorn Therapeutics Inc.Portfolio Gains Summary & Technical Confirmation Trade Alerts - Newser
Real time social sentiment graph for Foghorn Therapeutics Inc.Earnings Summary Report & High Yield Equity Trading Tips - Newser
Predicting Foghorn Therapeutics Inc. trend using moving averages2025 Sector Review & Proven Capital Preservation Methods - Newser
How sentiment analysis helps forecast Foghorn Therapeutics Inc.July 2025 Spike Watch & Community Consensus Trade Signals - Newser
Does Foghorn Therapeutics Inc. fit your quant trading modelRate Cut & Weekly High Potential Stock Alerts - Newser
Foghorn Therapeutics Inc. stock outlook for YEARQuarterly Profit Report & Reliable Trade Execution Plans - Newser
Forecasting Foghorn Therapeutics Inc. price range with options data2025 Price Targets & Long-Term Capital Growth Strategies - Newser
Real time pattern detection on Foghorn Therapeutics Inc. stockDay Trade & Real-Time Market Trend Scan - Newser
What the charts say about Foghorn Therapeutics Inc. todayQuarterly Trade Report & Reliable Momentum Entry Alerts - Newser
Will earnings trigger a reversal in Foghorn Therapeutics Inc.2025 Retail Activity & Accurate Buy Signal Notifications - Newser
Published on: 2025-08-30 23:31:55 - Newser
Published on: 2025-08-30 04:36:01 - Newser
Foghorn Therapeutics Inc. Reversal Rally May Surprise Bears getLinesFromResByArray error: size == 0 - thegnnews.com
Finanzdaten der Foghorn Therapeutics Inc-Aktie (FHTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Foghorn Therapeutics Inc-Aktie (FHTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Costa Carlos | Chief People Officer |
Sep 23 '24 |
Option Exercise |
3.72 |
857 |
3,188 |
857 |
| Costa Carlos | Chief People Officer |
Sep 20 '24 |
Sale |
10.04 |
35,756 |
358,990 |
0 |
| Costa Carlos | Chief People Officer |
Sep 23 '24 |
Sale |
10.17 |
857 |
8,716 |
0 |
| Costa Carlos | Chief People Officer |
Sep 18 '24 |
Option Exercise |
3.72 |
11,574 |
43,055 |
11,574 |
| Costa Carlos | Chief People Officer |
Sep 18 '24 |
Sale |
10.05 |
11,574 |
116,319 |
0 |
| Costa Carlos | Chief People Officer |
Sep 17 '24 |
Option Exercise |
3.72 |
10,272 |
38,212 |
10,272 |
| Costa Carlos | Chief People Officer |
Sep 16 '24 |
Option Exercise |
3.72 |
400 |
1,488 |
400 |
| Costa Carlos | Chief People Officer |
Sep 17 '24 |
Sale |
10.04 |
10,272 |
103,131 |
0 |
| Costa Carlos | Chief People Officer |
Sep 16 '24 |
Sale |
10.00 |
400 |
4,000 |
0 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):